MedDisAbirateron
type: MedicationDispense
node role: treeRoot
id:
  v: MedDisAbirateron
meta:
  profile:
    v: http://fhir.ch/ig/ch-core/StructureDefinition/ch-core-medicationdispense
    l: ch-core-medicationdispense
text:
  status:
    v: extensions
  div:
    v: Generated Narrative: MedicationDispense MedDisAbirateron Profile: CH Core MedicationDispense Indication Code: 21423.01 identifier: <a href="http://terminology.hl7.org/7.0.1/NamingSystem-uri.html" title="As defined by RFC 3986 (http://www.ietf.org/rfc/rfc3986.txt)(with many schemes defined in many RFCs). For OIDs and UUIDs, use the URN form (urn:oid:(note: lowercase) and urn:uuid:). See http://www.ietf.org/rfc/rfc3001.txt and http://www.ietf.org/rfc/rfc4122.txt #xD;#xA;#xD;#xA;This oid is used as an identifier II.root to indicate the the extension is an absolute URI (technically, an IRI). Typically, this is used for OIDs and GUIDs. Note that when this OID is used with OIDs and GUIDs, the II.extension should start with urn:oid or urn:uuid: #xD;#xA;#xD;#xA;Note that this OID is created to aid with interconversion between CDA and FHIR - FHIR uses urn:ietf:rfc:3986 as equivalent to this OID. URIs as identifiers appear more commonly in FHIR.#xD;#xA;#xD;#xA;This OID may also be used in CD.codeSystem.">Uniform Resource Identifier (URI)/urn:uuid:92e13e19-9bd4-43ec-807d-a78d6962bad3 status: Completed medication: Medication ABIRATERON Accord FCT 500 mg, blister 56 pce subject: Franz Muster Male, DoB: 1995-01-27 ( Medical record number) Performers - Actor * PractitionerRole authorizingPrescription: MedicationRequest: extension = 21423.01; identifier = UUID:f3ab7b8f-3eb4-4211-aba4-ce83c202f04e; status = active; intent = order; medication[x] = ->Medication ABIRATERON Accord FCT 500 mg, blister 56 pce; authoredOn = 2026-06-13 13:31:00+0000 type: First Fill - Complete quantity: 1 Package - unit of product usage (qualifier value) (Details: SNOMED CT code1681000175101 = 'Package - unit of product usage') daysSupply: 28 d (Details: UCUM coded = 'd') whenHandedOver: 2026-06-14 09:00:00+0000 receiver: Franz Muster Male, DoB: 1995-01-27 ( Medical record number) dosageInstruction text: 1 tablet in the morning, 1 tablet in the evening. To be taken at least 1h before or 2h after meals. pati…
contained: Medication
  id:
    v: AbirateronAccordTab500mg
  meta:
    profile:
      v: http://fhir.ch/ig/ch-core/StructureDefinition/ch-core-medication
      l: ch-core-medication
  code:
    coding:
      system:
        v: urn:oid:2.51.1.1
        l: 2.51.1.1
      code:
        v: 7680679500013
      display:
        v: ABIRATERON Accord FCT 500 mg, blister 56 pce
    coding:
      system:
        v: http://www.whocc.no/atc
        l: atc
      code:
        v: L02BX03
      display:
        v: abiraterone
    text:
      v: ABIRATERON Accord FCT 500 mg, blister 56 pce
  form:
    coding:
      system:
        v: urn:oid:0.4.0.127.0.16.1.1.2.1
        l: 0.4.0.127.0.16.1.1.2.1
      code:
        v: 10221000
      display:
        v: Film-coated tablet
    text:
      v: Film-coated tablet
  amount:
    numerator:
      value:
        v: 56
      unit:
        v: Tablet (unit of presentation)
      system:
        v: http://snomed.info/sct
        l: sct
      code:
        v: 732936001
    denominator:
      value:
        v: 1
      unit:
        v: Package - unit of product usage (qualifier value)
      system:
        v: http://snomed.info/sct
        l: sct
      code:
        v: 1681000175101
  ingredient:
    item: CodeableConcept
      text:
        v: Abiraterone acetate
    is active:
      v: true
  ingredient:
    item: CodeableConcept
      text:
        v: Lactose monohydrate
    is active:
      v: false
  ingredient:
    item: CodeableConcept
      text:
        v: Microcrystalline cellulose
    is active:
      v: false
  ingredient:
    item: CodeableConcept
      text:
        v: Sodium croscarmellose
    is active:
      v: false
  ingredient:
    item: CodeableConcept
      text:
        v: Hypromellose
    is active:
      v: false
  ingredient:
    item: CodeableConcept
      text:
        v: Sodium lauryl sulfate
    is active:
      v: false
  ingredient:
    item: CodeableConcept
      text:
        v: Colloidal anhydrous silica
    is active:
      v: false
  ingredient:
    item: CodeableConcept
      text:
        v: Magnesium stearate
    is active:
      v: false
  ingredient:
    item: CodeableConcept
      text:
        v: Polyvinyl alcohol
    is active:
      v: false
  ingredient:
    item: CodeableConcept
      text:
        v: Titanium dioxide
    is active:
      v: false
  ingredient:
    item: CodeableConcept
      text:
        v: Macrogol
    is active:
      v: false
  ingredient:
    item: CodeableConcept
      text:
        v: Talc
    is active:
      v: false
  ingredient:
    item: CodeableConcept
      text:
        v: Iron(III) oxide
    is active:
      v: false
extension:
  url:
    v: http://fhir.ch/ig/ch-core/StructureDefinition/ch-ext-epl-regulated-authorization-limitation-indication-code
    l: ch-ext-epl-regulated-authorization-limitation-indication-code
  value: String
    v: 21423.01
identifier:
  system:
    v: urn:ietf:rfc:3986
    l: 3986
status:
  v: completed
medication: Reference
  l: AbirateronAccordTab500mg
  reference:
    v: #AbirateronAccordTab500mg
subject:
  l: FranzMuster
  reference:
    v: Patient/FranzMuster
performer:
  actor:
    l: SchreibKraftAtGruppenpraxisCH
    reference:
      v: PractitionerRole/SchreibKraftAtGruppenpraxisCH
authorizing prescription:
  l: MedReqAbirateron
  reference:
    v: MedicationRequest/MedReqAbirateron
type:
  coding:
    system:
      v: http://terminology.hl7.org/CodeSystem/v3-ActCode
      l: v3-ActCode
    code:
      v: FFC
quantity:
  value:
    v: 1
  unit:
    v: Package - unit of product usage (qualifier value)
  system:
    v: http://snomed.info/sct
    l: sct
  code:
    v: 1681000175101
days supply:
  value:
    v: 28
  unit:
    v: d
  system:
    v: http://unitsofmeasure.org
    l: unitsofmeasure.org

v: 500

v: mg

v: mg

v: 1

v: Tablet (unit of presentation)

v: 732936001

v: 253.2

v: mg

v: mg

v: 1

v: Tablet (unit of presentation)

v: 732936001

v: d

v: 2026-06-14T09:00:00Z

l: FranzMuster
reference:
  v: Patient/FranzMuster

text:
  v: 1 tablet in the morning, 1 tablet in the evening. To be taken at least 1h before or 2h after meals.
patient instruction:
  v: To be taken at least 1h before or 2h after meals.
timing:
  repeat:
    frequency:
      v: 2
    period:
      v: 1
    period unit:
      v: d
    when:
      v: MORN
    when:
      v: EVE
route:
  coding:
    system:
      v: urn:oid:0.4.0.127.0.16.1.1.2.1
      l: 0.4.0.127.0.16.1.1.2.1
    code:
      v: 20053000
    display:
      v: Oral use
method:
  coding:
    system:
      v: urn:oid:0.4.0.127.0.16.1.1.2.1
      l: 0.4.0.127.0.16.1.1.2.1
    code:
      v: 0019
    display:
      v: Swallowing
dose and rate:
  dose: Quantity
    value:
      v: 1
    unit:
      v: Tablet (unit of presentation)
    system:
      v: http://snomed.info/sct
      l: sct
    code:
      v: 732936001

was substituted:
  v: false